Estrella Immunopharma Inc. (NASDAQ: ESLA)
$1.49
-0.0150 ( -1.00% ) 35.2K
Estrella Immunopharma Inc is a preclinical-stage biopharmaceutical company developing CD19 and CD22-targeted ARTEMIS T-cell therapies with the capacity to address treatment challenges for patients with blood cancers and solid tumors. Estrella's mission is to harness the evolutionary power of the human immune system to transform the lives of patients fighting cancer.
Market Data
Open
$1.49
Previous close
$1.50
Volume
35.2K
Market cap
$53.11M
Day range
$1.44 - $1.53
52 week range
$0.81 - $5.62
SEC Fillings
Form Type | Description | Pages | Date |
---|---|---|---|
8-k | 8K-related | 15 | Aug 18, 2023 |
10-q | Quarterly Reports | 60 | Aug 01, 2023 |
8-k | 8K-related | 13 | Aug 01, 2023 |
8-k | 8K-related | 14 | Jul 26, 2023 |
8-k | 8K-related | 14 | Jul 21, 2023 |
8-k | 8K-related | 15 | Jul 19, 2023 |
8-k | 8K-related | 15 | Jul 19, 2023 |
8-k | 8K-related | 14 | Jul 12, 2023 |